EN / ID
16 February 2023

To Increase COVID-19 Protection, ELNUSA Facilitates the Second Booster Vaccine

Jakarta, 16 February 2023 - PT Elnusa Tbk (ELNUSA, IDX: ELSA), a Subsidiary of PT Pertamina Hulu Energi incorporated in Pertamina Upstream Subholding held the 2nd covid-19 booster vaccination which was held in the Udaya Graha Room Elnusa Jakarta. The activity was held on 16-17 February 2023. In this activity, the target participants for vaccination included Elnusa officers and their families, work partners, Graha Elnusa tenants and the general public.

Symbolically, the second Booster vaccination was opened with the first and second injections marked by Elnusa Director of Operations Charles Harianto Lumbantobing and followed by Elnusa Finance Director Bachtiar Soeria Atmadja. On this occasion Charles and Bachtiar appealed and invited all Elnusa officers and their families to immediately take advantage of this moment to carry out a second booster vaccination with the aim of minimizing the risk of contracting the COVID-19 virus again.

Corporate Secretary Elnusa Asmal Salam stated that at the beginning of 2023 the COVID-19 cases in Indonesia were indeed decreasing. However, this has not discouraged the Company from remaining consistent and not being negligent about the prevention of COVID-19. "Seeing the latest developments when the government decided to intensify the implementation of the second booster vaccination, we welcome that the second booster vaccination event will be held immediately," said Asmal.

In this activity, Elnusa collaborated with the Pasar Minggu District Health Center as a provider of vaccination doses. Apart from that, Elnusa also cooperates with medical personnel from the Cilandak Marine Marine Hospital as a vaccinator. "The vaccine dose provided this time is 750 vaccine doses/day. The condition for being able to do this second booster vaccination is to have done the first booster vaccine with the types Sinovac, Astrazeneca, Pfizer, Moderna, and Janssen (J&J) with a distance of doses 3 to doses 4 at least 6 months," said Asmal.

Asmal added "This second vaccination activity is clear evidence of Elnusa's management's concern for workers' health rights, besides that through this activity it is hoped that it can be one of the Company's contributions in meeting herd immunity targets for the whole community," closed Asmal.

Back to News